Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term follow-up of neonatal thyroxine versus placebo in children with Down syndrome
NL-OMON33051Not yet recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Nov 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in Down syndrome comparing Thyroxine with Placebo (2 arms). Primary endpoint: Cognitive development. Planned start Nov 2009; status: not yet recruiting.
02
Drugs
levothyroxine sodium
03
Conditions
Down syndrome
Beyond the preview
Go deeper on NL-OMON33051.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON33051.